These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29575644)

  • 1. HLA-A*02:07 Allele Associates with Clarithromycin-Induced Cutaneous Adverse Drug Reactions in Chinese Patients.
    Chen SA; Zhang LR; Yang FP; Yang LL; Yang Y; Chen ZH; Jiang ML; Xiong H; Zhu HZ; Qi Z; Xing QH; Luo XQ
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123(3):308-313. PubMed ID: 29575644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-B*51:01 is strongly associated with clindamycin-related cutaneous adverse drug reactions.
    Yang Y; Chen S; Yang F; Zhang L; Alterovitz G; Zhu H; Xuan J; Yang X; Luo H; Mu J; He L; Luo X; Xing Q
    Pharmacogenomics J; 2017 Dec; 17(6):501-505. PubMed ID: 27527109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous reactions induced by oxcarbazepine in Southern Han Chinese: incidence, features, risk factors and relation to HLA-B alleles.
    He N; Min FL; Shi YW; Guo J; Liu XR; Li BM; Zhou JH; Ou YM; Liao JX; Liao WP
    Seizure; 2012 Oct; 21(8):614-8. PubMed ID: 22818943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hla-B alleles and lamotrigine-induced cutaneous adverse drug reactions in the Han Chinese population.
    Shi YW; Min FL; Liu XR; Zan LX; Gao MM; Yu MJ; Liao WP
    Basic Clin Pharmacol Toxicol; 2011 Jul; 109(1):42-6. PubMed ID: 21306565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HLA-A*02:01:01/-B*35:01:01/-C*04:01:01 haplotype associated with lamotrigine-induced maculopapular exanthema in Mexican Mestizo patients.
    Fricke-Galindo I; Martínez-Juárez IE; Monroy-Jaramillo N; Jung-Cook H; Falfán-Valencia R; Ortega-Vázquez A; Alonso-Vilatela ME; López-López M
    Pharmacogenomics; 2014; 15(15):1881-91. PubMed ID: 25495410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-A*02:01 allele is associated with tanshinone-induced cutaneous drug reactions in Chinese population.
    Zhu Q; Zhang Y; Xuan J; Yang F; Du B; Chen SA; Yan S; Jiang M; Zhu H; Xiong H; Luo X; Xing Q
    Pharmacogenomics J; 2020 Jun; 20(3):408-414. PubMed ID: 31792370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pilot association study of oxcarbazepine-induced mild cutaneous adverse reactions with HLA-B*1502 allele in Chinese Han population.
    Hu FY; Wu XT; An DM; Yan B; Stefan H; Zhou D
    Seizure; 2011 Mar; 20(2):160-2. PubMed ID: 21169036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of HLA-B*58:01 allele and allopurinol-induced cutaneous adverse drug reactions: evidence from 21 pharmacogenetic studies.
    Wu R; Cheng YJ; Zhu LL; Yu L; Zhao XK; Jia M; Wen CH; Long XZ; Tang T; He AJ; Zeng YY; Ma ZF; Zheng Z; Ni MZ; Cai GJ
    Oncotarget; 2016 Dec; 7(49):81870-81879. PubMed ID: 27835909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic susceptibility to the cross-reactivity of aromatic antiepileptic drugs-induced cutaneous adverse reactions.
    Wang W; Hu FY; Wu XT; An DM; Yan B; Zhou D
    Epilepsy Res; 2014 Aug; 108(6):1041-5. PubMed ID: 24856347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-C*12:02 is strongly associated with Xuesaitong-induced cutaneous adverse drug reactions.
    Yan S; Xiong H; Shao F; Zhang W; Yang F; Qi Z; Chen S; He L; Jiang M; Su Y; Zhu H; Qin S; Zhu Q; Luo X; Xing Q
    Pharmacogenomics J; 2019 Jun; 19(3):277-285. PubMed ID: 30237582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Research on Susceptible Genes and Immunological Pathogenesis of Cutaneous Adverse Drug Reactions in Chinese Hans.
    Yang F; Yang Y; Zhu Q; Chen SA; Fu X; Yan S; Meng C; Ma L; Sun X; Xu J; Luo X; Xing Q
    J Investig Dermatol Symp Proc; 2015 Jul; 17(1):29-31. PubMed ID: 26067314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-B*58:01 allele is associated with augmented risk for both mild and severe cutaneous adverse reactions induced by allopurinol in Han Chinese.
    Cao ZH; Wei ZY; Zhu QY; Zhang JY; Yang L; Qin SY; Shao LY; Zhang YT; Xuan JK; Li QL; Xu JH; Xu F; Ma L; Huang HY; Xing QH; Luo XQ
    Pharmacogenomics; 2012 Jul; 13(10):1193-201. PubMed ID: 22909208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-A*24:02 is associated with metronidazole-induced cutaneous adverse drug reactions in Han Chinese individuals: A pilot case-control study with both HLA gene and T cell receptor repertoire analysis.
    Yang F; Jiang M; Zhang W; Qiao Y; Chen SA; Wang D; Zhu H; Zhang J; Qin S; Zhu Q; Lv Y; Xing Q; Luo X
    Basic Clin Pharmacol Toxicol; 2020 Feb; 126(2):133-143. PubMed ID: 31483922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectrum of cutaneous adverse reactions to aromatic antiepileptic drugs and human leukocyte antigen genotypes in Thai patients and meta-analysis.
    Sukasem C; Sririttha S; Chaichan C; Nakkrut T; Satapornpong P; Jaruthamsophon K; Jantararoungtong T; Koomdee N; Medhasi S; Oo-Puthinan S; Rerkpattanapipat T; Klaewsongkram J; Rerknimitr P; Tuchinda P; Chularojanamontri L; Tovanabutra N; Suvannang N; Rungrotmongkol T; Saokaew S; Aekplakorn W; Puangpetch A
    Pharmacogenomics J; 2021 Dec; 21(6):682-690. PubMed ID: 34175889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between HLA-A*3201 allele and oxcarbazepine-induced cutaneous adverse reactions in Eastern Han Chinese population.
    Xu J; Shi X; Qiu Y; Zhang Y; Chen S; Shi Y; Deng Y
    Seizure; 2019 Feb; 65():25-30. PubMed ID: 30599396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population.
    Ozeki T; Mushiroda T; Yowang A; Takahashi A; Kubo M; Shirakata Y; Ikezawa Z; Iijima M; Shiohara T; Hashimoto K; Kamatani N; Nakamura Y
    Hum Mol Genet; 2011 Mar; 20(5):1034-41. PubMed ID: 21149285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-B*40:02 and DRB1*04:03 are risk factors for oxcarbazepine-induced maculopapular eruption.
    Moon J; Kim TJ; Lim JA; Sunwoo JS; Byun JI; Lee ST; Jung KH; Park KI; Jung KY; Jeon D; Yu KS; Jang IJ; Chu K; Lee SK
    Epilepsia; 2016 Nov; 57(11):1879-1886. PubMed ID: 27666425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians.
    Chen CB; Hsiao YH; Wu T; Hsih MS; Tassaneeyakul W; Jorns TP; Sukasem C; Hsu CN; Su SC; Chang WC; Hui RC; Chu CY; Chen YJ; Wu CY; Hsu CK; Chiu TM; Sun PL; Lee HE; Yang CY; Kao PH; Yang CH; Ho HC; Lin JY; Chang YC; Chen MJ; Lu CW; Ng CY; Kuo KL; Lin CY; Yang CS; Chen DP; Chang PY; Wu TL; Lin YJ; Weng YC; Kuo TT; Hung SI; Chung WH;
    Neurology; 2017 Jan; 88(1):78-86. PubMed ID: 27913699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA alleles and hypersensitivity to carbamazepine: an updated systematic review with meta-analysis.
    Grover S; Kukreti R
    Pharmacogenet Genomics; 2014 Feb; 24(2):94-112. PubMed ID: 24336023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.
    Ikeda H; Takahashi Y; Yamazaki E; Fujiwara T; Kaniwa N; Saito Y; Aihara M; Kashiwagi M; Muramatsu M
    Epilepsia; 2010 Feb; 51(2):297-300. PubMed ID: 19694795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.